Mutations in a SARS-CoV-2 variant affect how antibodies bind

The BA.2.87.1 variant shows changes in its spike protein that may reduce protection from existing antibodies.

The BA.2.87.1 variant has many mutations in its spike protein. These changes may allow the variant to escape recognition by preexisting antibodies.

Researchers studied how remodeling of the N-terminal domain (NTD) influences antigenic properties. The NTD is a part of the spike protein.

The study used structural and binding analyses on the BA.2.87.1 variant. This variant has 33 NTD mutations and large deletions.

The NTD shows increased flexibility in this variant. It also loses interaction with a heme-metabolite. This metabolite is known to facilitate the exposure of an immunodominant epitope.

An immunodominant epitope is a part of the protein that is a primary target for the immune system. These effects may reduce the neutralizing capacity of human convalescent antibodies.

The results show the intrinsic adaptability of the spike beyond the receptor-binding domain. This has implications for immune escape during viral evolution.

Key facts

  • The BA.2.87.1 variant has 33 mutations in the N-terminal domain.
  • Large deletions in the NTD do not substantially disrupt overall spike structure or pseudovirus infectivity.
  • The NTD in BA.2.87.1 exhibits increased flexibility.
  • Changes in the NTD may reduce the ability of human convalescent antibodies to engage the domain.

All sections

Edition